3-aminobenzamide has been researched along with Diabetic Retinopathy in 1 studies
Diabetic Retinopathy: Disease of the RETINA as a complication of DIABETES MELLITUS. It is characterized by the progressive microvascular complications, such as ANEURYSM, interretinal EDEMA, and intraocular PATHOLOGIC NEOVASCULARIZATION.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Obrosova, IG | 1 |
| Minchenko, AG | 1 |
| Frank, RN | 1 |
| Seigel, GM | 1 |
| Zsengeller, Z | 1 |
| Pacher, P | 1 |
| Stevens, MJ | 1 |
| Szabó, C | 1 |
1 other study available for 3-aminobenzamide and Diabetic Retinopathy
| Article | Year |
|---|---|
Poly(ADP-ribose) polymerase inhibitors counteract diabetes- and hypoxia-induced retinal vascular endothelial growth factor overexpression.
Topics: Animals; Benzamides; Cell Hypoxia; Diabetes Mellitus, Experimental; Diabetic Retinopathy; Enzyme Inh | 2004 |